List of Studies ( Metabolite:TG 44:0)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004133 | AN006851 | Metabolite profiling of portal and cardiac puncture plasma in C57Bl6 mice treated with Vancomycin or Metronidazole under a regular or high fat diet. | Blood | Mouse | Diabetes | Broad Institute of MIT and Harvard | LC-MS |
| ST004132 | AN006847 | Metabolite profiling of portal plasma, cardiac puncture plasma, and cecal contents of 129 T, 129 J, C57Bl6 mice. | Blood | Mouse | Diabetes | Broad Institute of MIT and Harvard | LC-MS |
| ST004132 | AN006847 | Metabolite profiling of portal plasma, cardiac puncture plasma, and cecal contents of 129 T, 129 J, C57Bl6 mice. | Cecal content | Mouse | Diabetes | Broad Institute of MIT and Harvard | LC-MS |
| ST004095 | AN006788 | Hep3B PNPLA3 wild type and PNPLA3(I148M) lipidomics | Cultured cells | Human | Cancer | Amgen | LC-MS |
| ST004093 | AN006784 | Autoimmune Disease Risk Gene ANKRD55 Promotes T Cell Proliferation and Th17 2 Effector Function Through Metabolic Modulation | T-cells | Mouse | Autoimmune disease | Broad Institute of MIT and Harvard | LC-MS |
| ST004049 | AN006694 | Comparison of lipidome from phagosomes containing Pam3csk4-beads vs. uncoupled-beads | Macrophages | Mouse | St Jude Children's Research Hospital | LC-MS | |
| ST003931 | AN006455 | Acylated putrescine therapeutic discovery for Inflammatory Bowel Diseases: HILIC-neg, C8-pos and C18-neg profiling of mouse fecal samples | Feces | Mouse | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003911 | AN006422 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 4 | Bacterial cells | Eggerthella lenta | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003911 | AN006422 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 4 | Bacterial cells | Fusobacterium nucleatum | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003910 | AN006419 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. | Bacterial cells | Bifidobacteria | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003910 | AN006419 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. | Bacterial cells | Clostridium | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003910 | AN006419 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. | Bacterial cells | Escherichia coli | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003910 | AN006419 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. | Bacterial cells | Streptococcus | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003814 | AN006271 | Sulfur Amino Acid Restriction Enhances Exercise Capacity in Mice by Boosting Fat Oxidation in Muscle - extensor digitorum longus (EDL) versus soleus (Sol) on Con and SAAR diet lipidomics | Muscle | Mouse | Princeton University | LC-MS | |
| ST003805 | AN006255 | Epigenetic changes, neuronal dysregulation and behavioral abnormalities in Zmym2+/- mutant mice, a genetic animal model of schizophrenia and neurodevelopmental disorders | Brain | Mouse | Neurodevelopment Disorder | Broad Institute of MIT and Harvard | LC-MS |
| ST003805 | AN006255 | Epigenetic changes, neuronal dysregulation and behavioral abnormalities in Zmym2+/- mutant mice, a genetic animal model of schizophrenia and neurodevelopmental disorders | Brain | Mouse | Schizophrenia | Broad Institute of MIT and Harvard | LC-MS |
| ST003785 | AN006220 | Sex differences in lipid profiles of visceral adipose tissue with obesity and gonadectomy | Tissue | Mouse | Obesity | University of Michigan | LC-MS |
| ST003710 | AN006087 | Integrating Metagenomics and Metabolomics to Study the Gut Microbiome and Host Relationships in Sports Across Different Energy Systems | Blood | Human | Universidad del Rosario | LC-MS | |
| ST003702 | AN006074 | Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion using Csf1r conditional KO | Liver | Mouse | University of Bonn | LC-MS | |
| ST003614 | AN005939 | Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion | Liver | Mouse | University of Bonn | LC-MS | |
| ST003514 | AN005769 | Highly reliable LC-MS lipidomics database for efficient human plasma profiling based on NIST SRM 1950 | Blood | Human | Universidad CEU San Pablo | LC-MS | |
| ST003438 | AN005650 | Unbiased genetic screening and metabolomics identifies glial adenosine metabolism as a therapeutic target in Parkinson’s disease | Fly Head | Fruit fly | Parkinsons disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003376 | AN005528 | Bempedoic acid improves diet-induced steatosis independent of hepatic ACLY | Liver | Mouse | Fatty liver disease | Salk Institute for Biological Studies | LC-MS |
| ST003364 | AN005512 | Deep lipidomic profiling reveals sex dimorphism of lipid metabolism in fibro-calcific aortic valve disease | Aortic valve tissue | Human | Heart disease | Technical University Dresden | LC-MS |
| ST003251 | AN005325 | Temperature change elicits lipidome adaptation in the simple organisms Mycoplasma mycoides and JCVI-syn3B | Minimal cell JCVI-syn3B | Mycoplasma mycoides | Environmental exposure | TU Dresden | LC-MS |
| ST003251 | AN005325 | Temperature change elicits lipidome adaptation in the simple organisms Mycoplasma mycoides and JCVI-syn3B | Mycoplasma mycoides | Mycoplasma mycoides | Environmental exposure | TU Dresden | LC-MS |
| ST003157 | AN005179 | Diet modulates the protective effects of dimethyl fumarate mediated by the immunometabolic neutrophil receptor HCA2 - Lipidomics | Blood | Mouse | Multiple sclerosis | University of Luebeck | LC-MS |
| ST003128 | AN005130 | Effect of high fat diet on serum lipidome and metabolome in CHCHD10 Mutant Mice | Blood | Mouse | Cardiomyopathy | Weill Cornell Medicine | LC-MS |
| ST003103 | AN005077 | Reinforcing the Evidence of Mitochondrial Dysfunction in Long COVID Patients using a Multiplatform Mass Spectrometry-based Metabolomics Approach | Blood | Human | COVID-19 | Universidad CEU San Pablo | GC-MS/LC-MS |
| ST003090 | AN005054 | Analysis of lipid profiles of N2A-Pz1-KO cells expressing tdTOMATO-vector (mock), TMEM120A, or TMEM120B | Cultured cells | Mouse | Rutgers University | LC-MS | |
| ST003051 | AN005002 | Shotgun lipidomics of breast cancer endocrine therapy persisters | Breast cancer cells | Human | Cancer | Dartmouth College | LC-MS |
| ST003040 | AN004989 | MM.1S Myeloma tumor cells and tumors made by subcutaneously injecting 1M Luc+/GFP+ MM.1S cells treated with 50 μM BMS309403 and Vehicle (PBS with a matched concentration of 5% DMSO) | Cultured cells | Human | Cancer | MaineHealth Institute for Research | LC-MS |
| ST002903 | AN004764 | Identification and targeting of microbial putrescine acetylation in bloodstream infections | Blood | Human | Septic shock | Broad Institute of MIT and Harvard | LC-MS |
| ST002843 | AN004652 | Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Tamoxifen) | Liver | Mouse | Cancer | Rutgers University | LC-MS |
| ST002843 | AN004653 | Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Tamoxifen) | Liver | Mouse | Cancer | Rutgers University | LC-MS |
| ST002842 | AN004651 | Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Fenofibrate) | Liver | Mouse | Cancer | Rutgers University | LC-MS |
| ST002827 | AN004616 | Multi-assay nutritional metabolomics profiling of low vitamin A status versus adequacy is characterized by reduced plasma lipid mediators among lactating women in the Philippines: A pilot study. | Blood | Human | California Polytechnic State University, San Luis Obispo | API-MS | |
| ST002817 | AN004584 | Investigation of metabolism in hypertrophic cardiomyopathy - Lipidomics | Heart | Mouse | Cardiomyopathy | University of California, San Francisco | LC-MS |
| ST002764 | AN004499 | Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis – a nested case-control study within the ATBC cohort | Blood | Human | Cancer | Icahn School of Medicine at Mount Sinai | LC-MS |
| ST002729 | AN004426 | Improved Endurance Capacity of Diabetic Mice during SGLT2 Inhibition: Potential Role of AICARP, an Endogenous AMPK Activator. | Muscle | Mouse | Diabetes | Medical Institute of Bioregulation, Kyushu University | LC-MS |
| ST002700 | AN004376 | Metabolomic analysis of maternal mid-gestation plasma and cord blood: lipidomics | Blood | Human | Autism | Columbia University | LC-MS |
| ST002536 | AN004173 | Effectors enabling adaptation to mitochondrial complex I loss in Hürthle cell carcinoma | Thyroid | Human | Cancer | Broad Institute of MIT and Harvard | LC-MS |
| ST002472 | AN004038 | Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Veillonella parvula cell and media profiling | Bacterial cells | Veillonella parvula | Ulcerative colitis | Broad Institute of MIT and Harvard | LC-MS |
| ST002471 | AN004034 | Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling | Feces | Human | Ulcerative colitis | Broad Institute of MIT and Harvard | LC-MS |
| ST002470 | AN004030 | Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human plasma profiling | Blood | Human | Ulcerative colitis | Broad Institute of MIT and Harvard | LC-MS |
| ST002438 | AN003972 | Ozone alters glycosphingolipid metabolism and exacerbates characteristics of asthma in mice | Lung | Mouse | Asthma | University of California, Davis | LC-MS |
| ST002422 | AN003944 | UBXD8 lipidomics from whole cells (Part 2) | Cultured cells | Human | University of Arizona | LC-MS | |
| ST002421 | AN003942 | UBXD8 lipidomics from whole cells (Part 1) | Cultured cells | Human | University of Arizona | LC-MS | |
| ST002409 | AN003926 | Spatial, temporal, and inter-subject variation of the metabolome along the human upper intestinal tract (MS RP positive data) | Intestine | Human | University of California, Davis | LC-MS | |
| ST002339 | AN003822 | Myriocin rescue of serine-associated hepatic lipid diversity | Liver | Mouse | Salk Institute for Biological Studies | LC-MS | |
| ST002247 | AN003671 | Microbiota and Health Study (Dhaka, Bangladesh) | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST002246 | AN003667 | Longitudinal fecal metabolomic profiles from mothers and their infants in the EDIA study | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST002135 | AN003496 | Alignment and Analysis of a Disparately Acquired Multi-Batch Metabolomics Study of Maternal Pregnancy Samples. (Part 2) | Blood | Human | University of Michigan | LC-MS | |
| ST002134 | AN003492 | Alignment and Analysis of a Disparately Acquired Multi-Batch Metabolomics Study of Maternal Pregnancy Samples (Part 1) | Blood | Human | University of Michigan | LC-MS | |
| ST002070 | AN003374 | Lipidomic Comparison of 2D and 3D Colon Cancer Cell Culture Models | Cultured cells | Human | Cancer | Ohio State University | LC-MS |
| ST002057 | AN003349 | Distinct Human Hepatocyte Lipidomics Profiles for Nonalcoholic Steatohepatitis and In Vitro-Induced Steatosis | Cultured cells | Human | NASH | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST002002 | AN003265 | A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 3) | Blood | Human | Myalgic encephalomyelitis/chronic fatigue syndrome | Columbia University | LC-MS |
| ST001989 | AN003241 | THEM6-mediated lipid remodelling sustains stress resistance in cancer (Part 3) | LNCaP cells | Human | Cancer | IGMM | LC-MS |
| ST001988 | AN003240 | THEM6-mediated lipid remodelling sustains stress resistance in cancer (Part 2) | LNCaP cells | Human | Cancer | IGMM | LC-MS |
| ST001960 | AN003195 | Lipidomics of brown adipocytes treated with d9-choline | Adipose tissue | Mouse | Juntendo University | LC-MS | |
| ST001949 | AN003173 | Plasma Metabolome Normalization in Rheumatoid Arthritis following initiation of Methotrexate and the Identification of Metabolic Biomarkers of Efficacy | Blood | Human | Rheumatoid arthritis | University of Kansas | GC-MS |
| ST001888 | AN003059 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001859 | AN003013 | dTor affects the fat body lipidome via Nep1r1, Ctdnep1 and Lipin | Insect tissue | Fruit fly | VIB-KU Leuven | MS(Dir. Inf.) | |
| ST001859 | AN003014 | dTor affects the fat body lipidome via Nep1r1, Ctdnep1 and Lipin | Insect tissue | Fruit fly | VIB-KU Leuven | MS(Dir. Inf.) | |
| ST001843 | AN002986 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part II) | Blood | Human | Fatty liver disease | University of California, Davis | GC-MS |
| ST001843 | AN002986 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part II) | Liver | Human | Fatty liver disease | University of California, Davis | GC-MS |
| ST001840 | AN002983 | Metabolomics of lung microdissections reveals region- and sex-specific metabolic effects of acute naphthalene exposure in mice (part I) | Liver | Mouse | Oxidative stress | University of California, Davis | GC-MS |
| ST001831 | AN002972 | Nested case–control study of environmental exposure within the ongoing Puerto Rico Testsite for Exploring Contamination Threats (PROTECT) pregnancy cohort (part II) | Blood | Human | University of Michigan | LC-MS | |
| ST001815 | AN002946 | Metabolic Markers of Methotrexate Response in Juvenile Idiopathic Arthritis | Blood | Human | Arthritis | University of Kansas | GC-MS/LC-MS |
| ST001794 | AN002913 | Metabolomics Analysis of Time-Series Gastrointestinal Lumen Samples | Jejunum | Human | University of California, Davis | LC-MS | |
| ST001738 | AN002829 | AdipoAtlas: A Reference Lipidome for Human White Adipose Tissue | Adipose tissue | Human | Obesity | University of Leipzig | LC-MS |
| ST001637 | AN002677 | A Metabolome Atlas of the Aging Mouse Brain | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001521 | AN002534 | Plasma metabolites of known identity profiled using hybrid nontargeted methods (part-III) | Blood | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST001519 | AN002526 | Stool metabolites of known identity profiled using hybrid nontargeted methods (part-I) | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST001451 | AN002426 | Eleostearic acid effects on TAGs and oxLipids | Breast cancer cells | Human | Cancer | Fox Chase Cancer Center | LC-MS |
| ST001363 | AN002269 | Monophasic lipidomics extraction in cancer cell lines | Hep G2 cells | Human | Cancer | Institute of Genetics and Molecular Medicine | LC-MS |
| ST001360 | AN002264 | Maternal blood lipidomics associated with severe preeclampsia | Blood | Human | Preeclampsia | University of Michigan | LC-MS |
| ST001269 | AN002109 | Exosomal lipids for classifying early and late stage non-small cell lung cancer | Blood | Human | Cancer | University of Kentucky | MS(Dir. Inf.) |
| ST001267 | AN002104 | Mass spectrometry-based lipidomics of oral squamous cell carcinoma tissue reveals aberrant cholesterol and glycerophospholipid metabolism | Tongue | Human | Cancer | University of Helsinki | MS(Dir. Inf.) |
| ST001211 | AN002018 | Metabolomic Markers of Methotrexate Response, In Vitro | Cultured cells | Human | University of Kansas | GC-MS/LC-MS | |
| ST001210 | AN002014 | Comprehensive UHPLC-MS/MS lipidomics profiling to study effects of betulin on keratinocytes | Keratinocytes | Human | Eberhard Karls University of Tübingen | LC-MS | |
| ST001192 | AN001987 | A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST001128 | AN001853 | WT and ΔSPT cultures of B. thetaiotaomicron grown in Minimal Media with or without d4-alanine (part IV) | Bacterial cells | Bacteroides thetaiotaomicron | Irritable bowel syndrome | Broad Institute of MIT and Harvard | LC-MS |
| ST001127 | AN001852 | Lipid profiling of caecal samples from GF mice colonized with B. thetaiotaomicron WT or the ΔSPT mutants (part III) | Cecum | Mouse | Irritable bowel syndrome | Broad Institute of MIT and Harvard | LC-MS |
| ST001126 | AN001851 | WT and ΔSPT cultures of B. thetaiotaomicron grown in Minimal Media (part II) | Bacterial cells | Bacteroides thetaiotaomicron | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST001125 | AN001850 | WT and ΔSPT cultures of B. thetaiotaomicron and B. ovatus grown BHI liquid media (part I) | Bacterial cells | Bacteroides ovatus | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST001125 | AN001850 | WT and ΔSPT cultures of B. thetaiotaomicron and B. ovatus grown BHI liquid media (part I) | Bacterial cells | Bacteroides thetaiotaomicron | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST001000 | AN001881 | Gut microbiome structure and metabolic activity in inflammatory bowel disease | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST000991 | AN001617 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IX) | Blood | Human | University of California, Davis | LC-MS | |
| ST000990 | AN001616 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VIII) | Blood | Human | University of California, Davis | LC-MS | |
| ST000989 | AN001615 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VII) | Blood | Human | University of California, Davis | LC-MS | |
| ST000988 | AN001614 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VI) | Blood | Human | University of California, Davis | LC-MS | |
| ST000987 | AN001613 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part V) | Blood | Human | University of California, Davis | LC-MS | |
| ST000986 | AN001612 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IV) | Blood | Human | University of California, Davis | LC-MS | |
| ST000985 | AN001611 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part III) | Blood | Human | University of California, Davis | LC-MS | |
| ST000984 | AN001610 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part II) | Blood | Human | University of California, Davis | LC-MS | |
| ST000983 | AN001609 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (Part I) | Blood | Human | University of California, Davis | LC-MS | |
| ST000923 | AN001516 | Longitudinal Metabolomics of the Human Microbiome in Inflammatory Bowel Disease | Feces | Human | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST000917 | AN001500 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine | Urine | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000916 | AN001494 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma | Blood | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000915 | AN001488 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver | Liver | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000879 | AN001432 | Diet, genetics and gut microbiome drive dynamic changes in plasma metabolites [plasma] | Blood | Mouse | Broad Institute of MIT and Harvard | LC-MS | |
| ST000670 | AN001027 | Exposure to high fat diets and bisphenol | Blood | Mouse | University of Michigan | LC-MS | |
| ST000668 | AN001023 | Diet manipulation on the lipidome | Blood | Human | University of Michigan | LC-MS | |
| ST000114 | AN000192 | SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium | B-cells | Human | Cancer | University of Kentucky | GC-MS/LC-MS |
| ST000113 | AN000190 | SIRM Analysis of human P493 cells under hypoxia in [U-13C/15N] labeled Glutamine medium (Positive ion mode FTMS) | B-cells | Human | Cancer | University of Kentucky | GC-MS/LC-MS |
| ST000110 | AN000183 | SIRM Analysis of human P493 cells under hypoxia in [U-13C/15N] labeled Glutamine medium (Both positive and ion mode FTMS) | B-cells | Human | University of Kentucky | GC-MS/LC-MS | |
| ST000005 | AN000012 | Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin | Macrophages | Mouse | LIPID MAPS | GC-MS/LC-MS |
